High Net Worth Angel Investing Strategy: A Data-Driven Guide
Learn a systematic approach to high net worth angel investing: limit allocations to 5-8% of net worth, diversify across 15-25 companies over 3-5 years, and prepare for 10+ year hold periods to navigate power law economics.
April 13, 2026
Section 1202 Qualified Small Business Stock Guide
Section 1202 QSBS allows individual investors to exclude up to 100% of capital gains from qualifying small business stock held for 5+ years, with a $10 million per-issuer cap. Understand eligibility, acquisition dates, and tax benefits.
April 13, 2026
Angel Investor Groups in Seattle Washington
Seattle hosts three structured angel investor groups: Alliance of Angels (180+ members), Seattle Angel Conference ($150K-$200K pooled funds), and Mossy Ventures. All require accredited investor status and operate on cohort-based models with formal due diligence.
April 13, 2026
Privacy Infrastructure Series B Funding 2026: Why Alcatraz Won
Alcatraz raised $50M Series B in April 2026 by solving enterprise AI's compliance nightmare: biometric authentication without storing faces. The approach attracted Fortune 100 customers and major airports.
April 13, 2026
Privacy-First AI Series B Funding: Alcatraz's $50M Raise
Alcatraz, founded by a former Apple Face ID engineer, raised $50M in Series B funding for its privacy-first AI physical security platform that verifies identity without data collection or surveillance.
April 13, 2026
SEC Crypto Asset Framework: March 2026 Ruling Changes Fundraising
The SEC's March 2026 interpretation establishes a five-category token taxonomy, ending a decade of compliance uncertainty. Token projects can now restructure offerings under digital commodities, collectibles, tools, stablecoins, and digital securities.
April 13, 2026
Precision Fermentation Funding: Government-Backed Series B Wins
France 2030's Ecotechnologies 2 fund led Standing Ovation's $34.2M Series B, proving government-corporate partnerships now outperform pure venture capital for regulated biotech scaling.
April 13, 2026
Defense-Tech Now Competes With AI for Mega-Round Capital
Defense-tech companies are pulling institutional capital at scale comparable to AI infrastructure firms. Hermeus's $350M Series C signals a fundamental shift in venture capital allocation toward hardware-backed national security solutions.
April 13, 2026
AI Physical Security Funding: Alcatraz's $50M Series B
Alcatraz, an AI-powered physical access control startup founded by a former Apple Face ID engineer, raised $50M in Series B funding, bringing total funding past $100M. The round reflects growing venture capital interest in infrastructure with defensible moats.
April 13, 2026
Court Square's CallTower Deal: The Middle-Market PE Playbook
Court Square Capital Partners acquired CallTower in April 2026, demonstrating the middle-market PE strategy that institutional LPs use to generate consistent returns through operational leverage and proven cash flows.
April 13, 2026
SEC CFTC Crypto Framework 2026: Why Accredited Investors Won
On March 17, 2026, the SEC and CFTC issued a joint interpretation establishing the first formal classification framework for crypto assets. Accredited investors who understand the GENIUS Act stablecoin compliance pathway now have 8 months before implementation.
April 13, 2026
Hermeus Hits $1B Valuation: Defense Tech's $350M Wake-Up Call
Hermeus secured $350M Series C funding at $1B valuation to develop Mach 3+ unmanned aircraft for U.S. military, signaling institutional capital's shift toward defense tech hardware with government contracts.
April 13, 2026